title: Biomedical implications of a thrombus-specific US contrast agent.
authors.affiliation: ImaRx Therapeutics, Inc, Tucson, AZ 85719, USA.
authors.forename: Evan C
authors.initials: EC
authors.lastname: Unger
authors.forename: Terry O
authors.initials: TO
authors.lastname: Matsunaga
authors.forename: Thomas P
authors.initials: TP
authors.lastname: McCreery
authors.forename: Robert H
authors.initials: RH
authors.lastname: Sweitzer
mesh_terms: D000818:Animals; D003287:Contrast Media / Q000008:administration & dosage*; D004195:Disease Models, Animal; D004285:Dogs; D010743:Phospholipids / Q000008:administration & dosage; D010974:Platelet Aggregation / Q000502:physiology*; D013927:Thrombosis / Q000000981:diagnostic imaging*; D014463:Ultrasonography
chemical_list: D003287:Contrast Media; C112670:MRX 408; D010743:Phospholipids